Eken, H. Nur http://orcid.org/0000-0002-2627-4689
Spotts, Crystal
Panny, Benjamin
Griffo, Angela
Degutis, Michelle
Cruz, Nicolas
Bell, Elizabeth
Do-Nguyen, Kevin
Wallace, Meredith L.
Mathew, Sanjay J. http://orcid.org/0000-0002-2715-6641
Howland, Robert H.
Price, Rebecca B. http://orcid.org/0000-0002-7590-4325
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH113857)
Article History
Received: 27 September 2023
Revised: 9 April 2024
Accepted: 12 April 2024
First Online: 16 May 2024
Competing interests
: RBP work has been funded by the NIH. RBP is the named inventor on a University of Pittsburgh-owned patent filing related to the combination intervention described in this letter. MLW has served as a statistical consultant for Health Rhythms, Noctem Health, and Sleep Number Bed. SJM is supported through the use of facilities and resources at the Michael E. Debakey VA Medical Center, Houston, Texas, and receives support from The Menninger Clinic. SJM has served as a consultant to Alkermes, Allergan, Almatica, Axsome Therapeutics, Biohaven, BioXcel Therapeutics, Clexio Biosciences, Eleusis, EMA Wellness, Engrail Therapeutics, Greenwich Biosciences, Intra-Cellular Therapies, Janssen, Levo Therapeutics, Neurocrine, Perception Neuroscience, Praxis Precision Medicines, Relmada Therapeutics, Sage Therapeutics, Seelos Therapeutics, and Signant Health. He has received research support from Biohaven Pharmaceuticals, Boehringer-Ingelheim, Merck, Sage Therapeutics, and VistaGen Therapeutics. All other authors report no financial conflicts of interest to disclose.